ProfileGDS5678 / 1455439_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.936599
GSM967853U87-EV human glioblastoma xenograft - Control 212.924599
GSM967854U87-EV human glioblastoma xenograft - Control 313.154199
GSM967855U87-EV human glioblastoma xenograft - Control 412.827599
GSM967856U87-EV human glioblastoma xenograft - Control 513.323699
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 112.683699
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 212.452199
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 312.928599
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 413.106799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 112.969499
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 212.484199
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 312.829499
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.998699
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 512.919699